Beximco Pharmaceuticals Plc.
(LSE) BXP
Beximco Pharmaceuticals Plc. Financials at a Glance
Market Cap
£180.90M
Revenue (TTM)
BDT 46.34B
Net Income (TTM)
BDT 6.35B
EPS (TTM)
£0.00
P/E Ratio
0.00
Dividend
£0.00
Beta (Volatility)
-0.02 (Low)
Dividend
£0.00
Beta (Volatility)
-0.02 (Low)
Price
£0.41
Volume
0
Open
£0.43
Price
£0.41
Volume
0
Open
£0.43
Previous Close
£0.41
Daily Range
£0.47 - £0.47
52-Week Range
£0.33 - £0.52
Estimated Earnings Date
Sep 2, 2026
Dividend
£0.00
Beta (Volatility)
-0.02 (Low)
Price
£0.41
Volume
0
Open
£0.43
Previous Close
£0.41
Daily Range
£0.47 - £0.47
52-Week Range
£0.33 - £0.52
Estimated Earnings Date
Sep 2, 2026
BXP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Beximco Pharmaceuticals Plc.
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,122
CEO
Iqbal Ahmed
Website
www.beximcopharma.comHeadquarters
Dhaka, 1205, BD
BXP Financials
Key Financial Metrics (TTM)
Gross Margin
44%
Operating Margin
20%
Net Income Margin
13%
Return on Equity
0%
Return on Capital
15%
Return on Assets
8%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
27.20%
Stock Overview
Market Cap
£180.90M
Shares Outstanding
446.11M
Volume
0
Avg. Volume
0
Financials (TTM)
Gross Profit
BDT 19.63B
Operating Income
BDT 8.67B
EBITDA
BDT 10.64B
Operating Cash Flow
BDT 8.36B
Capital Expenditure
-BDT 2.23B
Free Cash Flow
BDT 6.13B
Cash & ST Invst.
BDT 1.05B
Total Debt
BDT 6.03B
Beximco Pharmaceuticals Plc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
BDT 12.30B
+12.8%
Gross Profit
BDT 5.57B
+13.9%
Gross Margin
45.29%
N/A
Market Cap
£180.90M
N/A
Market Cap/Employee
£30.15K
N/A
Employees
6,000
N/A
Net Income
BDT 1.83B
+27.6%
EBITDA
BDT 2.61B
-4.2%
Quarterly Fundamentals
Total Cash
BDT 2.36B
+75.0%
Total Debt
BDT 6.19B
-18.6%
Accounts Receivable
BDT 4.63B
+24.8%
Inventory
BDT 15.10B
+12.7%
Long Term Debt
BDT 2.02B
+11.5%
Short Term Debt
BDT 4.17B
-28.0%
Return on Assets
8.41%
N/A
Return on Invested Capital
14.51%
N/A
Free Cash Flow
-BDT 279.87M
-121.7%
Operating Cash Flow
BDT 1.04B
-41.0%